Middle East Medical Cannabis Market, by Distribution Channel
| Label | Cannabidiol | Tetrahydrocannabinol |
|---|---|---|
| 2018 | 0.49 USD Mn | 0.18 USD Mn |
| 2019 | 1.87 USD Mn | 0.7 USD Mn |
| 2020 | 3.74 USD Mn | 1.4 USD Mn |
| 2021 | 6.02 USD Mn | 2.26 USD Mn |
| 2022 | 8.7 USD Mn | 3.27 USD Mn |
| 2023 | 11.96 USD Mn | 4.51 USD Mn |
| 2024 | 15.96 USD Mn | 6.04 USD Mn |
| 2025 | 21.57 USD Mn | 8.18 USD Mn |
| 2026 | 26.86 USD Mn | 10.22 USD Mn |
| 2027 | 32.65 USD Mn | 12.46 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Middle East Medical Cannabis Market, by Derivative, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 37 Mn in 2026 and is projected to reach USD 45 Mn by 2027 — a gain of about 22% over the forecast period, translating to a CAGR in the double digits.
- Cannabidiol is the biggest of 2 groups as of 2027, at 32. 65M USD (72% of the combined total).
- What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
- By 2027, Cannabidiol alone is expected to reach USD 33 Mn, with Tetrahydrocannabinol at USD 12 Mn.
Market Dynamics
Cannabidiol is the biggest of 2 groups as of 2027, at 32.65M USD (72% of the combined total).
Tetrahydrocannabinol follows at 12.46M USD, 62% smaller than Cannabidiol.
Cannabidiol: 490.00K USD to 32.65M USD, 6563% higher by 2027.
Tetrahydrocannabinol: 180.00K USD in 2018 to 12.46M USD by 2027, up 6822%.
The fastest mover is Tetrahydrocannabinol, up 6822% over the period — a steeper climb than any of the other 2 groups here.
The 2-group total: 670.00K USD in 2018, 45.11M USD by 2027, 6633% overall.
Making Sense Of 2 Series At Once
This is a comparison chart, 2 groups at once — the interesting question is usually how the gap between them changes, not the value of any single group in isolation.
Size and growth rate are two different questions here — a series can be small in absolute terms and still be growing the fastest of the group. Check both before drawing a conclusion.
The most practical way to read this is relative: set the Middle East Medical Cannabis market figures beside other regions or segments of the same market to see where growth is concentrated.
Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllMiddle East Medical Cannabis Market, by Application
Middle East Medical Cannabis Market, by Route of Administration
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



